WHY PERFECTHA
Four pillars. One promise.
Every promise stands on a pillar. Every pillar stands on evidence.
Reversible & Pure Heritage
100% made in France, 19 years of clinical use — a reversible, pure formula.*
PILLAR 1
Defined Structure & Precision
E-BRID®: an engineered 3-network architecture — contours with precision.
PILLAR 2
Proven Effective & Satisfaction
Long-lasting results, documented patient satisfaction.
PILLAR 3
* Except for the needles. Data refers to the original Perfectha. 'Reversible' refers to the inherent properties of hyaluronic acid.
Smart Accessibility
Premium European quality, the confident first choice.
PILLAR 4
PURE HERITAGE & SAFETY
Made in Lyon. Proven for 19 years.
ObvieLine laboratory, Lyon — ISO 13485 & CE since 2007*.
>90%
Non-cytotoxic — tested on fibroblast cell lines.*
CELL VIABILITY
<2 ppm
Very low IL-8 release (~50 pg/ml).**
NON-DETECTABLE BDDE
2007
Data of the original Perfectha
CE CERTIFIED SINCE
* Except for the needles. Data on file (August 2021). Data refers to the original Perfectha.
0.005%
Sinclair post-market data, Jan 2024 – Dec 2025.
ADVERSE EVENTS
* Regazzini D, Fares J. Prospective study, Perfectha Derm Subskin, n=126; Park KY, et al. J Eur Acad Dermatol Venereol. 2014;28:565–8.
** Sinclair internal test report; Koenig B. IL-8 release analysis, MMD study report, August 2020.
PROVEN SATISFACTION
Results patients endorse.
86% rated 'much improved' or 'very much improved' one week after treatment — excellent results remaining at 6 months.*
Improvement maintained for up to 18 months in a 126-patient prospective study.**
* Talarico S, et al. Surg Cosmet Dermatol. 2010;2(2):83–6. Open multicenter study, n=87 (Perfectha Derm; nasolabial folds and lips).
** Regazzini D, Fares J. Prospective study, Perfectha Derm Subskin, n=126.
READY WHEN YOU ARE
Start the conversation with confidence.
Find a trained professional near you, or talk to the Perfectha team about training and distribution.